ANNUAL REPORT 2021
DEEPMATTER GROUP PLC
®
CONTENTS
OVERVIEW
1
Our Offering and Strategy
STRATEGIC REPORT
2 Chair's Statement
4 CEO Statement
7 CFO Statement
8 Principal Risks and Uncertaines
9 Secon 172(1) statement
GOVERNANCE
10 Corporate Governance
16 The Board
18 Directors' Report
19 Directors' Remuneraon Report
21 Audit & Risk Commiee Report
BECAUSE MOLECULES MATTER
24 Independent Auditor's Report to the members of Deepmaer Group PLC
FINANCIAL STATEMENTS
30 Consolidated statement of comprehensive income
31 Consolidated statement of financial posion
32 Consolidated statement of changes in equity
33 Consolidated statement of cash flows
34 Notes to the consolidated financial statements
55 Company statements
58 Notes to the company financial statements
61 Company informaon (list of Directors, Officers and Advisors)
62 Noce of Annual General Meeng
OVERVIEW
DeepMaer is building and commercialising the most powerful cloud based plaorm enabling sciensts to capture chemical reacon data, easily perform and opmise laboratory experiments, reacons, and analyse scienfic outcomes using machine learning. This will allow the greater use of arficial intelligence, to a stage where chemicals can be autonomously synthesised with robocs.
At the heart of this strategy is a unique perspecve and approach to collecng data. DeepMaer has developed data rich technologies used by today's expert users, early adopters and futurists. This includes bringing together cloud-based soſtware, with rounely used laboratory hardware and unique sensor feeds that collect unique data throughout the me-course of a chemical reacon. This novel data collected in a clean and structured manner means that machine learning analysis can be applied with confidence to enable aconable knowledge - thereby increasing producvity, discovery and compliance gains.
Being cloud-based, our plaorms enable chemists to work together effecvely; sharing the details of their experiments from anywhere and in real-me, so that work is not needlessly duplicated, me and money wasted, and ulmately so new discoveries may be made faster and more safely.
Visit:www.deepmaer.io and follow @deepmaergroup
2
DeepMatter Group Plc Annual Report 2021
CHAIR'S STATEMENT
I am satisfied with the progress DeepMatter has made in 2021. We made good inroads, signing up a number of important new customers, hiring key opinion leaders into the Group, and progressing our SmartChemistry™ platform. Overall revenue progress was behind the Board's initial expectations in 2021, but the progress made in the second half of 2021 in signing new partnerships provides a solid base for 2022.
The pharmaceucal and chemistry industries are focused on delivering world class products through substanal discovery and development programmes. This now rounely includes the extracon and use of vast amounts of data from laboratory experiments and instruments which requires a move towards automated data capture and integrity, analysis and reporng, which is accessible by machine learning.
DeepMaer's technology plaorm is being increasingly recognised in the market as a means to enable this move. The SmartChemistry™ plaorm enables the vast amounts of proprietary data to be combined with proprietary algorithms. Our investment in our technology over the last few years, which connues at pace ensures a great user experience and a product with sustainable compeve advantage, providing unique insights and producvity gain.
Much of our effort in 2021 was as a direct result of feedback from customers, telling us what maers to them. We ended the year with a plaorm that addresses an increasing market need and which has been enhanced by the guiding feedback of industry users.
Science is at the core of everything we do. Our team and advisors are comprised of high-quality science and technologists that shape and implement our vision. We connue to seek to secure the best talent in our sector and are focused in combining scienfic excellence with a unwavering commercial outlook.
We are aware that our people are our most valuable asset. As we have moved through the phases of the Covid-19 pandemic, our team has shown parcular resilience. From enforced remote working in early 2021, the opportunity to now adopt hybrid working has been embraced reinvigorang collaboraon between colleagues. The Group connues to priorise communicaon and flexibility for staff whilst we help them adapt to a combined physical and virtual environment. The Group also is increasing its focus on providing connuous professional development for the staff, and increasing opportunies to spend me with our user and customer base.
STRATEGIC REPORT
3
CURRENT TRADING AND OUTLOOK
Although the Group made good progress in developing some new partnerships, the overall commercial progress was behind the Board's inial expectaons in 2021, as a result of deals slipping from H2 2021 to 2022.
Over the last few months, the Group has launched its SmartChemistry plaorm and signed up new partnerships.
For example, since the year end, the Group entered into a mulyear licensing and collaboraon agreement with AI-driven drug discovery company Standigm. DeepMaer provides access to its proprietary data and algorithms via its SmartChemisty™ plaorm. This will enable Standigm to be more efficient and producve in its drug discovery programmes through deeper data insights and analysis.
Karen Bach
Non-Execuve Chair
26th April 2022
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Deepmatter Group plc published this content on 27 April 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 27 April 2022 06:14:06 UTC.